No menu items!

Brazil’s Health cites risk of myocarditis in children to justify longer interval between vaccine doses

RIO DE JANEIRO, BRAZIL - Special Secretary for the Fight against Covid-19 Rosana Leite de Melo cited in a press conference on Wednesday, January 5, the alleged risk of myocarditis (proven rare) in the administration of the vaccine against Covid-19 in children aged 5 to 11.

The Secretary justified the Ministry's adoption of a longer interval than recommended by ANVISA for the administration of the vaccine to children. ANVISA had suggested 21 days, but the Ministry of Health decided to adopt 56 (eight weeks).

"The benefit is greater, it is much better for anyone if the interval is . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content